Calithera Biosciences Funding: $40M Raised, Series A (2024)
Calithera Biosciences is a Biotech company based in South San Francisco. It has raised $40M in total funding. Latest round: Series A.
Calithera Biosciences funding overview
Calithera Biosciences is a Biotech company based in South San Francisco. Calithera Biosciences has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in July 2024. The round record for Calithera Biosciences runs through 2024; nothing later has been disclosed. Investors on record include Morgenthaler Ventures, U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures, Mission Bay Capital. 5 distinct backers are named across the disclosed rounds.
Calithera Biosciences at a glance
Total raised
$40M
Latest round
Series A
Latest round date
July 2024
Industry
Biotech
Headquarters
South San Francisco
Notable investors
Morgenthaler Ventures, U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures, Mission Bay Capital
Frequently asked about Calithera Biosciences funding
How much has Calithera Biosciences raised?
Calithera Biosciences has raised $40M in total disclosed funding across the rounds on record.
Who has invested in Calithera Biosciences?
Morgenthaler Ventures, U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures, Mission Bay Capital are named among the investors backing Calithera Biosciences.
What was the latest Calithera Biosciences funding round?
The most recent disclosed round is a Series A, announced in July 2024.
Where is Calithera Biosciences based?
Calithera Biosciences is based in South San Francisco.
What sector does Calithera Biosciences operate in?
Calithera Biosciences is tracked under Biotech from South San Francisco, with $40M in disclosed funding.
When did Calithera Biosciences last raise?
The last disclosed Calithera Biosciences round closed in July 2024 at Series A.
Calithera Biosciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in South San Francisco below to benchmark round size and investor mix.
